260
Participants
Start Date
January 19, 2017
Primary Completion Date
May 28, 2019
Study Completion Date
July 16, 2019
GDC-0853
Participants received GDC-0853 at dosages of 150 or 200mg as per the dosing schedules described above.
Placebo
Participants received matching placebo to GDC-0853 at dosages of 150 and 200mg as per the dosing schedules described above.
Chang Gung Memorial Hospital - Linkou, Taoyuan District
Medical Center Excelsior OOD, Sofia
"UMHAT Sv. Ivan Rilski, EAD", Sofia
"MC Synexus - Sofia, EOOD", Sofia
Hospital Italiano de La Plata, La Plata
MHAT Plovdiv, Plovdiv
CER San Juan Centro Polivalente de Asistencia e Investigacion Clinica, San Juan
"Medical Center Nov Rehabilitatsionen Tsentar, EOOD", Stara Zagora
"Medical Center Teodora, EOOD", Rousse
National Taiwan University Hospital, Taipei
New York University School of Medicine, New York
Charite Research Organisation GmbH; Phase - I Unit of Hematology and Oncology, Berlin
Saint Lawrence Health System, Canton
Complejo Hospitalario Universitario A Coruña, A Coruña
Hospital Universitario de Saltillo, Saltillo
Centro de Investigacion Alberto Bazzoni S.A. de C.V., Torreón
Shanahan Rheumatology & Immunology, PLLC, Raleigh
Hospital General Universitario Gregorio Marañon, Madrid
Omega Research Consultants, Orlando
RASF-Clinical Research Center, Boca Raton
Bay Area Arthritis and Osteoporosis, Brandon
Clinical Research of West Florida, Tampa
University of Alabama at Birmingham, Birmingham
Ohio State University Clinical Trials Management Office, Columbus
Hospital Clinico Universitario de Valladolid; Servicio de Reumatologia, Valladolid
Consultorio Particular del Dr. Miguel Cortes Hernandez, Cuernavaca
Dermacross, Santiago
Via Christi Research, a division of Via Christi Hospitals Wichita, Inc., Wichita
Ochsner Clinic Foundation, Baton Rouge
The Arthritis & Diabetes Clinic, Inc.; Research, Monroe
Accurate Clinical Research, Houston
Hospital Central Dr Ignacio Morones Prieto, San Luis Potosí City
Arthritis Clinic Of Central Texas, San Marcos
Tekton Research Inc, Austin
Centro de Reumatologia y Ortopedia, Barranquilla
Institute of Arthritis Research, Idaho Falls
Albuquerque Clinical Trials, Albuquerque
Valerius Medical Group & Research Ctr of Greater Long Beach, Los Alamitos
Unidad de Atencion Medica e Investigacion en Salud S.C., Mérida
Medicity S.A.S., Bucaramanga
Servimed S.A.S., Bucaramanga
CTR Estudios SPA, Providencia
Centro de Estudios Reumatológicos, Santiago
SOMEAL, Santiago
Accurate Clinical Research, Houston
Organizacion Medica de Investigacion, Buenos Aires
APRILLUS, Buenos Aires
Centro Medico Privado de Reumatologia; Reumathology, San Miguel
CEDOES - Diagnóstico e Pesquisa, Vitória
CIP - Centro Internacional de Pesquisa X; Pesquisa Clinica, Goiânia
Hospital das Clinicas - UFMG, Belo Horizonte
CMiP - Centro Mineiro de Pesquisa*X*, Juiz de Fora
Edumed - Educação e Saúde SA, Curitiba
Hospital Moinhos de Vento, Porto Alegre
Centro de Pesquisas em Diabetes - CPD, Porto Alegre
Clinica de Neoplasias Litoral, Itajaí
Faculdade de Medicina do ABC - FMABC, Santo André
Hospital Estadual Mario Covas, Santo André
Hospital Abreu Sodré - AACD, São Paulo
Biomedica, Santiago
CEQUIN - Fundación Cardiomet Eje Cafetero, Armenia
Centro Integral de Reumatologia del Caribe SAS CIRCARIBE SAS, Barranquilla
Hospital Pablo Tobon Uribe, Medellín
Hospital Angeles Lindavista, México
Konkuk University Medical Center, Seoul
The Catholic University of Korea St.Mary's Hospital, Seoul
Hospital Universitari Vall d'Hebron, Barcelona
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City
University College London Hospital, London
Guy's Hospital; Louise Coote Lupus Unit, London
Lead Sponsor
Genentech, Inc.
INDUSTRY